Peptide Cancer Vaccine Market Dynamics, Regional Insights, Competitive Analysis by 2026
Peptide cancer vaccines aim to activate the immune system to eradicate cancer cells. These vaccines contain the biochemical information that is needed to generate antigen?specific T cells to elicit anticancer responses and contain one or more short or long amino acid sequences as tumor antigens, combined with vaccine adjuvant. Recent researches conducted using peptide cancer vaccines have resulted in negative outcomes. This in turn has led researchers to consider the approach as outdated and no longer viable for cancer treatment....
View full press release